Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Depression 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Anxiety Disorders 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Prostatic Hyperplasia 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell, Marginal Zone 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Fatigue 2

Interventions

Nivolumab 7 cemiplimab 6 Specimen Handling 5 HhAntag691 5 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Biopsy 4 sonidegib 3 pembrolizumab 3 CTLA-4 Antigen 3 relatlimab 2 prednylidene 2 deltacortene 2 daromun 2 Surgical Procedures, Operative 2 Standard of Care 2 Prednisone 2 Observation 2 Aminolevulinic Acid 2 tocilizumab 1 talimogene laherparepvec 1 poly ICLC 1 flt3 ligand protein 1 X-Rays 1 Watchful Waiting 1 Vitamin D 1 Tomography, Optical Coherence 1 Therapeutics 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Therapeutics × 1 year × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡